Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00991120 · ClinicalTrials.gov registry record

Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study

A clinical trial of Heart Failure, sponsored by Medtronic Cardiac Rhythm and Heart Failure.

Completed
Registry status
165
Enrollment target
19
Study locations

NCT00991120: Completed study of Heart Failure, sponsored by Medtronic Cardiac Rhythm and Heart Failure.

NCT00991120 is a study of Heart Failure that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 165 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (92% lower). The trial reports 19 study locations across 17 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00991120, a study of Heart Failure, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.

COMPLETED
Registry status
165 participants
Enrollment target
19
Study locations

Study Summary

The purpose of the Extension Phase of the COMPASS-HF study is to continue to observe the safety of the Chronicle® Implantable Hemodynamic Monitor (IHM) system and Chronicle ICD system and provide study doctors continued access to the heart pressure information recorded by the Chronicle devices which may be used to help manage heart failure. The Extension Phase of the COMPASS-HF study is limited to people who have already received the investigational system and are currently enrolled in a Chronicle IHM or ICD study.

Conditions Studied

Heart Failure

Interventions

  • DEVICE Chronicle Implantable Hemodynamic Monitor (IHM) System, Chronicle Implantable Cardioverter Defibrillator (ICD)

Study Locations (19)

Ohio

  • - Cincinnati
  • - Columbus

Pennsylvania

  • - Lancaster
  • - Philadelphia

Alabama

  • - Birmingham

Illinois

  • - Springfield

Indiana

  • - Fort Wayne

Iowa

  • - Davenport

Massachusetts

  • - Boston

Minnesota

  • - Rochester

Trial Details

FieldValue
Enrollment Target 165 participants
Start Date 2009-10
Est. Completion 2013-04

Sponsor

Medtronic Cardiac Rhythm and Heart Failure

115 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00991120

The ClinicalTrials.gov registry entry for NCT00991120 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 165 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (92% lower). The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Chronicle Implantable Hemodynamic Monitor (IHM) System, Chronicle Implantable Cardioverter Defibrillator (ICD) is the first listed.

NCT00991120 reports 19 study locations spanning 17 distinct geographic areas - top geographies include Ohio, Pennsylvania, Alabama.

Frequently Asked Questions

What is clinical trial NCT00991120 about?

NCT00991120 is a clinical study titled "Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study". The purpose of the Extension Phase of the COMPASS-HF study is to continue to observe the safety of the Chronicle® Implantable Hemodynamic Monitor (IHM) system and Chronicle ICD system and provide study doctors continued access to the heart pressure information recorded by the Chronicle devices which...

What is the current status of trial NCT00991120?

This trial is currently completed. The enrollment target is 165 participants. The study started on 2009-10. Estimated completion is 2013-04.

What conditions does trial NCT00991120 study?

This clinical trial studies the following conditions: Heart Failure.

What interventions are being tested in trial NCT00991120?

The interventions under investigation include: Chronicle Implantable Hemodynamic Monitor (IHM) System, Chronicle Implantable Cardioverter Defibrillator (ICD) (DEVICE).

Who is sponsoring clinical trial NCT00991120?

This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00991120 being conducted?

This trial has 19 study locations across Alabama, Illinois, Indiana, Iowa, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Heart Failure

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.